Posts

Showing posts from July, 2022
Image
Wockhardt Ltd: Buy for superb returns! Face Value: Rs.5 CMP: Rs.212.40. Market Cap: Rs.3,012 crore. Market Cap: Rs.3059.84 crore. CEPS: Rs.2.22 Total Revenue in FY22: Rs.1,372.00 crore. Introduction : Wockhardt is a leading, research-based global healthcare enterprise, with interests in pharmaceuticals, biotechnology, and has a network of advanced Super Speciality Hospitals. Wockhardt is a true Indian MNC employing 8600 Associates from 21 different nationalities worldwide. It has 3 (three) research centers and 12 (twelve) manufacturing plants. Its products include pharmaceutical and bio-pharmaceutical formulations, active pharmaceutical ingredients (APIs), and vaccines. Photo : Moneycontrol.com Wockhardt Hospitals, a subsidiary of Wockhardt Ltd, is an Indian tertiary care and super speciality healthcare network. These hospitals provide services in Cardiology, Orthopedics, Neurology, Gastroenterology, Urology, and other specialties. Photo : Live Mint. Wockhardt is headquartered in Mumba...
Image
  Winning Strokes The Indian bourses have Surprisingly changed colour from a green to red once again, though there are as such not much negativite news Except that relentless FII selling. The BSE Sensex is now trading at 53,165.64 down 126.82 points (-0.13%), while the Nifty is seen at 15,817.10 down 37.15 points (-0.12%).  The BSE Sensex has come down from 600 - plus points up to the current, 100 - plus down, after the European markets showed red tickers in the opening trade. However, there is not much negativite news as far as the India's stock markets are concerned. I feel the markets should bounce back, in laste afternoon trade. -------------- By the way, Google searches for the term *bear market* recently reached their second-highest level since the Covid outbreak. This indicates that market participants are concerned about the current state of the global stock markets. ============= Meanwhile, according to a 2 July Wconomic Times report: When we look at the historical Ni...